Article Versions Notes

Porcellati F, Di Mauro S, Mazzieri A, Scamporrino A, Filippello A, De Fano M, Fanelli CG, Purrello F, Malaguarnera R, Piro S. Glucagon as a Therapeutic Approach to Severe Hypoglycemia: After 100 Years, Is It Still the Antidote of Insulin? Biomolecules. 2021; 11(9):1281. https://doi.org/10.3390/biom11091281

Porcellati, Francesca, Stefania Di Mauro, Alessio Mazzieri, Alessandra Scamporrino, Agnese Filippello, Michelantonio De Fano, Carmine Giuseppe Fanelli, Francesco Purrello, Roberta Malaguarnera, and Salvatore Piro. 2021. "Glucagon as a Therapeutic Approach to Severe Hypoglycemia: After 100 Years, Is It Still the Antidote of Insulin?" Biomolecules 11, no. 9: 1281. https://doi.org/10.3390/biom11091281

Porcellati, F., Di Mauro, S., Mazzieri, A., Scamporrino, A., Filippello, A., De Fano, M., Fanelli, C. G., Purrello, F., Malaguarnera, R., & Piro, S. (2021). Glucagon as a Therapeutic Approach to Severe Hypoglycemia: After 100 Years, Is It Still the Antidote of Insulin? Biomolecules, 11(9), 1281. https://doi.org/10.3390/biom11091281